Source-verified competitive intelligence across gene, cell, and T-cell-engager therapy — the entry point to the BioAlma platform.
Browse three ways — Modalities (by technology) · Diseases (by indication) · Companies (by company).
Briefs are the surface. The platform adds live dashboards, BD and medical affairs CRM, continuous monitoring, and custom analysis.
See the platform →Browse by technology. Each modality brief is built to order and delivered live — request the one you care about.
Pick an indication; we build a fresh, source-verified brief across every company working in it.
Pick a company; we build a fresh, source-verified brief and walk you through it in a short working session.
See the whole platform in a 30-minute walkthrough.
Book a demo